Michael T. Cyrus

FDA investigator

Appears on 12 documents from 2021 to 2025, most often at sites in California. Most often cites general requirements (21 CFR 211.160).

12
Documents on file
4.9
Observations per 483
2021
First seen
2025
Most recent

What they cite most

From 59 observations

Activity by year

2021: 1, 2022: 3, 2023: 1, 2024: 2, 2025: 5

Where

California 5 · Arizona 1 · Colorado 1 · Florida 1 · Indiana 1 · Ohio 1

Is Michael T. Cyrus coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

12 documents, newest first
FirmOpen
483 CareFusion 213, LLCOct 24, 2025 · El Paso, Texas
483 Eli Lilly and CompanyMay 20, 2025 · Indianapolis, Indiana
483 Ajinomoto Althea, IncMay 9, 2025 · San Diego, California
483 PCI San Diego, Inc.May 9, 2025 · San Diego, California
483 Nostrum Laboratories, Inc.Mar 13, 2025 · Bryan, Ohio
483 Jubilant HollisterStier LLCJun 6, 2024 · Spokane, Washington
483 McGuff Pharmaceuticals, Inc.Jan 26, 2024 · Santa Ana, California

About this profile

What does Michael T. Cyrus inspect?

Michael T. Cyrus appears on 12 documents on file covering 10 sites, most often in California.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.113 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Michael T. Cyrus is dated Oct 24, 2025.